• Company
• SK Group's Pharma companies make successive success
• by Lee, Seok-Jun Jul 30, 2021 05:48am

• Company
• Emgality and Ajovy were also approved
• by Kim, Jin-Gu Jul 30, 2021 05:47am

• Company
• Chong Kun Dang applied for Lucentis biosimilar
• by Chon, Seung-Hyun Jul 30, 2021 05:47am

• Policy
• Teva's new migraine drug Fremanezumab is released in Korea
• by Lee, Tak-Sun Jul 30, 2021 05:47am

• Company
• Sales of Takeda’s drugs 'acquired by Celltrion' drop 9%
• by Kim, Jin-Gu Jul 29, 2021 05:52am

• Company
• Anterogen to finish analysis for its diabetic foot ulcer Tx
• by Lee, Seok-Jun Jul 29, 2021 05:52am

• Company
• Viatris and Organon's sales are sluggish
• by Kim, Jin-Gu Jul 29, 2021 05:52am

• Policy
• MSD's Sinemet products have been withdrawn
• by Lee, Tak-Sun Jul 29, 2021 05:52am

• Company
• Daewoong's COVID drug PO is effective for patients over 50
• by Lee, Seok-Jun Jul 29, 2021 05:52am

• Company
• Nitrosamines test plan must also be submitted
• by Chon, Seung-Hyun Jul 28, 2021 05:56am